RECRUITINGN/A

Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Enrollment

600 participants

Sites

2 locations

Start Date

January 2020

Completion

January 2025

Cervical Intraepithelial Neoplasia

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

600

participants

Sites

locations

Duration

7.0 years

total trial span

Rate

pts/month needed

Jan 2020Month 75 of 84Jan 2025

89% of trial timeline elapsed9 months to primary endpoint

At 2 sites, each site needs to enroll approximately 3.5 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

HPV recurrence

2 years

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia.

Caia Carlotta, De Maria Francesca, Sopracordevole Francesco et al.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)2026

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

RECRUITINGN/A

Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Enrollment

600 participants

Sites

2 locations

Start Date

January 2020

Completion

January 2025

Cervical Intraepithelial Neoplasia

Enrollment & Timeline

Recruiting

Target enrollment (estimated)

Target N

600

participants

Sites

locations

Duration

7.0 years

total trial span

Rate

pts/month needed

Jan 2020Month 75 of 84Jan 2025

89% of trial timeline elapsed9 months to primary endpoint

At 2 sites, each site needs to enroll approximately 3.5 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

HPV recurrence

2 years

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia.

Caia Carlotta, De Maria Francesca, Sopracordevole Francesco et al.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)2026

DOI PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (2)